About: Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (en) Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (nl)
skos:prefLabel	Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (en) Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (nl)
name	Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (en) Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (nl)
title	wds:Q65367605-F6EC1AA6-8077-4F44-93D6-0ACCBA02B503
title	Phase 1 Multicenter, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (en)
end time	wds:Q65367605-D783CC68-49F4-4959-A799-CE3CD8BB22F0
end time	2014-05-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65367605-9EA29BB4-2258-4D6B-B147-AFAB7C575948
instance of	clinical trial
start time	wds:Q65367605-B2FE383F-8E53-49AC-814D-CA8967A34835
start time	2013-04-01 00:00:00Z (xsd:dateTime)
country	wds:Q65367605-572767E7-2B32-443E-B749-8929ABCD37D9
country	United States of America
research site	wds:Q65367605-D90AF552-D940-4F92-B7D5-7FAEDE39EC21
research site	Rainier Clinical Research Center
minimum age	wds:Q65367605-FCFAD000-4857-4369-A39B-CF2D129A3BBD
minimum age	18 (xsd:decimal)
medical condition	wds:Q65367605-FF2C8A2A-1DCF-405E-80AE-41FC9054A66E
medical condition	diabetes
number of participants	wds:Q65367605-99C8D0A0-D71D-41AD-808D-529AEF50534C
number of participants	37 (xsd:decimal)
maximum age	wds:Q65367605-89D5E67B-8D7B-42B8-B71C-D86AA1BB4A21
maximum age	65 (xsd:decimal)
study type	wds:Q65367605-2520A698-7627-43CF-930D-809E68B91230
study type	interventional study
ClinicalTrials.gov ID	wds:Q65367605-10B53D32-B8BB-46FB-AFD8-5962BFC825B7
ClinicalTrials.gov ID	NCT01835730
clinical trial phase	wds:Q65367605-B1C635AB-AC45-4270-B825-685ACD2FBE73
clinical trial phase	phase I clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65367605

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software